Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 46 Gynecologic 12 CNS 8 Tumor-Agnostic 5 Sarcoma 5 Genitourinary 2 Thoracic 1 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1

Conditions

Hematologic Neoplasms 1

Interventions

venetoclax 190 Cyclophosphamide 123 Azacitidine 112 Cytarabine 108 fludarabine 91 Specimen Handling 74 Biopsy 53 Daunorubicin 42 Methotrexate 41 Dexamethasone 38 Rituximab 34 blinatumomab 32 Vincristine 32 Decitabine 31 fludarabine phosphate 30 Injections 28 Granulocyte Colony-Stimulating Factor 28 Whole-Body Irradiation 26 Magnetic Resonance Spectroscopy 26 obinutuzumab 25 Idarubicin 25 acalabrutinib 23 Prednisone 23 Mycophenolic Acid 23 Melphalan 21 Busulfan 21 gilteritinib 19 Mercaptopurine 19 Doxorubicin 19 ibrutinib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × abemaciclib × Other hematologic neoplasm × Clear all

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡